Not surprising that he's disappointed at the share price, certainly one to keep an eye on at these levels even taking into account issues mentioned above.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025